Trial: 202008087

Phase 2, Multicenter, Randomized Study of DS-1062a in Advanced or Metastatic Non-Small Cell Lung Cancer with Actionable Genomic Alterations and Previously Treated with Kinase Inhibitor Therapy and Platinum-based Chemotherapy with or without Prior Immunotherapy


II (Cancer Control)

Principal Investigator

Waqar, Saiama

Disease Site


Learn more about this study at: